Colorectal Cancer Clinical Trials in Pittsburgh

Showing 281-297 of 297 trials

Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer

NCT00004931

Randomized phase III trial to compare the effectiveness of fluorouracil plus leucovorin with or without oxaliplatin in treating patients who have stage II or stage III colon cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which combination chemotherapy regimen is more effective for colon cancer

Stage II Colon CancerStage III Colon Cancer

National Cancer Institute (NCI)2,472 participantsStarted Feb 2000

Pittsburgh, Pennsylvania, United States

COMPLETED< 1 mile

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

NCT00410579

RATIONALE: Learning about quality of life, symptoms, and health behaviors in colorectal cancer survivors may help to determine the long-term effects of colon and rectal cancer treatments and may help to improve the quality of life for future cancer survivors. PURPOSE: This clinical trial is looking at patient-reported outcomes in long-term survivors of colon and rectal cancers.

Colorectal CancerFatigueLong-term Effects Secondary to Cancer Therapy in Adults+2 more

NSABP Foundation Inc744 participantsStarted Nov 2006

Aurora, Colorado, United States • Boulder, Colorado, United States • Colorado Springs, Colorado, United States +197 more locations

Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Colorectal Cancer Trials in Other Cities

A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Study of XL281 in Adults With Solid Tumors

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer

A Study of ABT-751 in Patients With Colorectal Cancer

Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.

Other Conditions in Pittsburgh